EUVIMEDEUVIMED entdecken
Open Access

Retail Availability of Intoxicating Cannabis and Mushroom Products Across Eleven U.S. Cities: Sales Persist Despite Prohibitions

Cassidy R LoParco, Matthew E Rossheim, Kayla K Tillett, Yuxian Cui, Miranda Johnson, Morgan Speer, Darby Mihelich, Hermela Amdeta, Diane Ndisebuye, Carla J Berg

Journal of Studies on Alcohol and Drugs · 29.05.2026

DOI: 10.15288/jsad.26-00013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Studies on Alcohol and Drugs, online erschienen am 29.05.2026. Verfasst von Cassidy R LoParco und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Prevention and Community Health, Milken Institute School of Public Health, George Washington University, Washington, DC, USA. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Retail sales of intoxicants, including derived intoxicating cannabis products (DICPs) such as delta-8 tetrahydrocannabinol (THC) and hallucinogenic mushrooms, have rapidly increased throughout the US, despite their sale being federally illegal. This study assessed DICP and hallucinogenic mushroom availability in US smoke shops with differing DICP and psilocybin laws.

Methods

In May-October 2025, using Google’s Incognito mode, we searched “smoke shop in [city, state]” across eleven cities in states (California, Colorado, Florida, Maryland, New York, Nevada, Oregon, Pennsylvania, Texas, Virginia, Washington) with differing legal contexts for THC and mushrooms (7 explicitly prohibited DICP sales, 2 decriminalized psilocybin, Amanita was not explicitly illegal in any). We called each store (n=1,023) to assess product availability. Bivariate tests assessed differences by state laws.

Results

73.0% (n=747/1,023) answered the phone and responded about DICP availability: 51.4% (n=384/747) reported selling DICPs (39.6% DICPs illegal vs. 80% not explicitly illegal, p

Schlagwörter

Stichwörter der Autor:innen

hemp-derived cannabinoidsmarketingpublic health policy

Autor:innen und Institutionen

  • Department of Prevention and Community Health, Milken Institute School of Public Health, George Washington University, Washington, DC, USA.
  • Department of Health Administration and Health Policy, College of Public Health, University of North Texas Health Science Center, Fort Worth, TX, USA.
  • George Washington Cancer Center, George Washington University, Washington, DC, USA.

Förderung

  • NIDA NIH HHS

Zitieren

APA

LoParco, C. R., Rossheim, M. E., Tillett, K. K., Cui, Y., Johnson, M., Speer, M., Mihelich, D., Amdeta, H., Ndisebuye, D., & Berg, C. J. (2026). Retail Availability of Intoxicating Cannabis and Mushroom Products Across Eleven U.S. Cities: Sales Persist Despite Prohibitions. Journal of Studies on Alcohol and Drugs. https://doi.org/10.15288/jsad.26-00013

Vancouver

LoParco CR, Rossheim ME, Tillett KK, Cui Y, Johnson M, Speer M, et al. Retail Availability of Intoxicating Cannabis and Mushroom Products Across Eleven U.S. Cities: Sales Persist Despite Prohibitions. Journal of Studies on Alcohol and Drugs. 2026. doi:10.15288/jsad.26-00013

BibTeX
@article{LoParco2026,
  author = {LoParco, Cassidy R and Rossheim, Matthew E and Tillett, Kayla K and Cui, Yuxian and Johnson, Miranda and Speer, Morgan and Mihelich, Darby and Amdeta, Hermela and Ndisebuye, Diane and Berg, Carla J},
  title = {Retail Availability of Intoxicating Cannabis and Mushroom Products Across Eleven U.S. Cities: Sales Persist Despite Prohibitions},
  journal = {Journal of Studies on Alcohol and Drugs},
  year = {2026},
  doi = {10.15288/jsad.26-00013}
}
Kostenlos starten →